| Product Name | Anti-Phospho-ADRB2 (Thr68) antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Immunogen | Synthetic peptide conjugated with KLH. |
| Modification | p-Thr68 |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
| Gene Symbol | ADRB2 |
|---|---|
| Gene Synonyms | BAR ARB2 B2AR ADRBR ADRB2R BETA2AR |
| Gene Full Name | adrenoceptor beta 2 |
| Gene Summary | This gene encodes beta-2-adrenergic receptor which is a member of the G protein-coupled receptor superfamily. This receptor is directly associated with one of its ultimate effectors, the class C L-type calcium channel Ca(V)1.2. This receptor-channel complex also contains a G protein, an adenylyl cyclase, cAMP-dependent kinase, and the counterbalancing phosphatase, PP2A. The assembly of the signaling complex provides a mechanism that ensures specific and rapid signaling by this G protein-coupled receptor. This receptor is also a transcription regulator of the alpha-synuclein gene, and together, both genes are believed to be associated with risk of Parkinson's Disease. This gene is intronless. Different polymorphic forms, point mutations, and/or downregulation of this gene are associated with nocturnal asthma, obesity, type 2 diabetes and cardiovascular disease. [provided by RefSeq, Oct 2019] |
| Alternative Names | ADRB2 ADRB2_HUMAN ADRB2R ADRBR Adrenergic beta 2 receptor surface Adrenoceptor beta 2 surface B2AR BAR beta 2 adrenoceptor Beta 2 adrenoreceptor Beta-2 adrenergic receptor Beta-2 adrenoceptor Beta-2 adrenoreceptor BETA2AR Catecholamine receptor OTTHUMP00000160386 |
| Molecular Weight(MW) | 46 kDa |
| Cellular Localization | Cell membrane,Golgi apparatus,Membrane. |
| SwissProt ID | P07550 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | Shipped at 4°C. Store at +4°C short term (1-2 weeks). Store at -20°C long term. Avoid freeze / thaw cycle. |
| Storage Buffer | Purified antibody in PBS with 0.05% sodium azide,40% Glycerol. |
